{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:52:36Z","timestamp":1761486756459},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNCI Journal of the National Cancer Institute"],"published-print":{"date-parts":[[2001,11,21]]},"DOI":"10.1093\/jnci\/93.22.1680","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:19:55Z","timestamp":1027721995000},"page":"1680-1681","source":"Crossref","is-referenced-by-count":1,"title":["Anthrax as a Cancer Drug?"],"prefix":"10.1093","volume":"93","author":[{"given":"F. B.","family":"Dunn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["JNCI Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/93\/22\/1680\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:13:56Z","timestamp":1503573236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/93.22.1680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,21]]},"references-count":0,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2001,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/93.22.1680","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,21]]}}}